Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Rayson

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Histopathology|June 10, 2026
Pathological assessment of tumour beds in breast excisions post-neoadjuvant therapy: a retrospective cohort studyAngela Cheng, Penelope Barnes, Daniel Rayson, et al.
Neuroendocrinology|March 17, 2026
Real-World Observational Study of Somatostatin Analogs and Rescue Medication Usage for Neuroendocrine Tumors in CanadaDaniel Rayson, Myriam Troesch, Callahan LaForty, et al.
Journal of Oncology Practice|November 28, 2012
Adherence to clinical practice guidelines for adjuvant chemotherapy for colorectal cancer in a Canadian province: a population-based analysisDaniel Rayson, Robin Urquhart, Martha Cox, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 31, 2007
Comparison of elapsed times from breast cancer detection to first adjuvant therapy in Nova Scotia in 1999/2000 and 2003/04Daniel Rayson, Nathalie Saint-Jacques, Tallal Younis, et al.
Mayo Clinic Proceedings|August 6, 2014
Terry Fox: Canadian cancer research activist whose "Marathon of Hope" inspired millionsDavid P Steensma, Daniel Rayson, Marc A Shampo, et al.
Journal of Cutaneous Pathology|September 30, 2017
Primary large cell neuroendocrine carcinoma of the skin: An under-recognized entity and a mimic of metastatic diseaseIan Marie Lano, Daniel Rayson, Thomas Arnason, et al.
Cancer Treatment Reviews|March 25, 2008
Metastatic breast cancer: the role of pegylated liposomal doxorubicin after conventional anthracyclinesShailendra Verma, Susan Dent, Benjamin J W Chow, et al.
The Breast Journal|May 13, 2010
Flat epithelial atypia on breast needle core biopsy: a retrospective study with clinical-pathological correlationTsu-Yee Joseph Lee, Rebecca F Macintosh, Daniel Rayson, et al.
Breast Cancer Research and Treatment|February 25, 2012
Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancerNathan W D Lamond, Chris Skedgel, Daniel Rayson, et al.
Journal of the National Cancer Institute. Monographs|April 14, 2010
Interfaces across the cancer continuum offer opportunities to improve the process of careStephen H Taplin, Steve Clauser, Anne B Rodgers, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Histopathology|June 10, 2026
Pathological assessment of tumour beds in breast excisions post-neoadjuvant therapy: a retrospective cohort studyAngela Cheng, Penelope Barnes, Daniel Rayson, et al.
Neuroendocrinology|March 17, 2026
Real-World Observational Study of Somatostatin Analogs and Rescue Medication Usage for Neuroendocrine Tumors in CanadaDaniel Rayson, Myriam Troesch, Callahan LaForty, et al.
Journal of Oncology Practice|November 28, 2012
Adherence to clinical practice guidelines for adjuvant chemotherapy for colorectal cancer in a Canadian province: a population-based analysisDaniel Rayson, Robin Urquhart, Martha Cox, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 31, 2007
Comparison of elapsed times from breast cancer detection to first adjuvant therapy in Nova Scotia in 1999/2000 and 2003/04Daniel Rayson, Nathalie Saint-Jacques, Tallal Younis, et al.
Mayo Clinic Proceedings|August 6, 2014
Terry Fox: Canadian cancer research activist whose "Marathon of Hope" inspired millionsDavid P Steensma, Daniel Rayson, Marc A Shampo, et al.
Journal of Cutaneous Pathology|September 30, 2017
Primary large cell neuroendocrine carcinoma of the skin: An under-recognized entity and a mimic of metastatic diseaseIan Marie Lano, Daniel Rayson, Thomas Arnason, et al.
Cancer Treatment Reviews|March 25, 2008
Metastatic breast cancer: the role of pegylated liposomal doxorubicin after conventional anthracyclinesShailendra Verma, Susan Dent, Benjamin J W Chow, et al.
The Breast Journal|May 13, 2010
Flat epithelial atypia on breast needle core biopsy: a retrospective study with clinical-pathological correlationTsu-Yee Joseph Lee, Rebecca F Macintosh, Daniel Rayson, et al.
Breast Cancer Research and Treatment|February 25, 2012
Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancerNathan W D Lamond, Chris Skedgel, Daniel Rayson, et al.
Journal of the National Cancer Institute. Monographs|April 14, 2010
Interfaces across the cancer continuum offer opportunities to improve the process of careStephen H Taplin, Steve Clauser, Anne B Rodgers, et al.
Pageof 9